drugset
drugset / Trial / NCT01352689

CKD-828(80/2.5mg) Pharmacokinetic Study_2nd

NCT01352689 ↗

Phase 1 Completed 67 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the pharmacokinetic characteristics of CKD-828(Fixed Dose Combination Tablet; Telmisartan and S-Amlodipine) in healthy volunteer.

Timeline

Start
2011-04
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject S-amlodipine Unknown 2.5 mg Oral
Subject Telmisartan Other / unclassified 80 mg Oral

Indications

hypertensive disorder